Meredith Irwin
Affiliations: | University of Toronto, Toronto, ON, Canada |
Area:
Microbiology Biology, Bioinformatics BiologyGoogle:
"Meredith Irwin"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Niazi MK, Chung JH, Heaton-Johnson KJ, et al. (2016) Advancing clinicopathologic diagnosis of high-risk neuroblastoma using computerized image analysis and proteomic profiling. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society |
| Morgenstern DA, Soh SY, Stavropoulos DJ, et al. (2014) Metachronous neuroblastoma in an infant with germline translocation resulting in partial trisomy 2p: a role for ALK? Journal of Pediatric Hematology/Oncology. 36: e193-6 |
| Gonzalez-Cano L, Hillje AL, Fuertes-Alvarez S, et al. (2013) Regulatory feedback loop between TP73 and TRIM32. Cell Death & Disease. 4: e704 |
| Blanch A, Robinson F, Watson IR, et al. (2013) Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity. Plos One. 8: e66436 |
| Wang Y, Roche O, Xu C, et al. (2012) Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proceedings of the National Academy of Sciences of the United States of America. 109: 4892-7 |
| Chung J, Grant RI, Kaplan DR, et al. (2011) Special AT-rich binding protein-2 (SATB2) differentially affects disease-causing p63 mutant proteins. The Journal of Biological Chemistry. 286: 40671-80 |
| Chung J, Lau J, Cheng LS, et al. (2010) SATB2 augments ΔNp63α in head and neck squamous cell carcinoma. Embo Reports. 11: 777-83 |
| Chung J, Irwin MS. (2010) Targeting the p53-family in cancer and chemosensitivity: triple threat. Current Drug Targets. 11: 667-81 |
| Wolter J, Angelini P, Irwin M. (2010) p53 family: Therapeutic targets in neuroblastoma. Future Oncology (London, England). 6: 429-44 |
| Roberts AM, Watson IR, Evans AJ, et al. (2009) Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Research. 69: 9056-64 |